Stay updated with breaking news from Loss Attributable. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Advanced RG6501 (OpRegen®) Development in Partnership with Roche and GenentechPublished OPC1 Phase 1/2a Clinical Study Results in Journal of Neurosurgery: SpineCompleted Key Activities to Support Planned Regulatory Interactions for OPC1 and VAC2Expanded Collaboration with Advanced BioMatrix for HyStem® Cell Drug Del...
Previously announced agreement for F-star Therapeutics to be acquired by invoX Pharma; transaction expected to close in the second half of 2022 License Agreement with Takeda to Develop and... | August 11, 2022
11.08.2022 - -Prioritizing the advancement of novel oncolytic adenovirus (OV) platform- -Cash balance as of August 1, 2022 of $53.5 million, including the additional $3 million in gross proceeds from convertible preferred financing extends funding for business ...
~ Revenue increases 514% year-over-year ~~ 21 physician workshop events completed ~LOS GATOS, CA/ ACCESSWIRE / August 11, 2022 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon Medical" or the "Company"), a
Investor Conference Call to be Held Today at 5:00 PM Eastern Time SAN DIEGO, Aug. 11, 2022 /PRNewswire/ -- Nuvve Holding Corp. , a green energy technology company that provides a...